Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs
暂无分享,去创建一个
K. Eguchi | K. Ichinose | M. Umeda | S. Fukui | T. Koga | S. Kawashiri | N. Iwamoto | M. Tamai | Hideki Nakamura | T. Origuchi | A. Kawakami | Y. Ueki | T. Aramaki | Y. Endo | S. Tsuji | A. Takatani | R. Sumiyoshi | T. Igawa | M. Okamoto | T. Shimizu